- Patent Title: High-throughput drug and genetic assays for cellular transformation
-
Application No.: US15560977Application Date: 2016-03-24
-
Publication No.: US11807895B2Publication Date: 2023-11-07
- Inventor: Asaf Rotem , Kevin Struhl , Paul Blainey , Liyi Xu
- Applicant: THE BROAD INSTITUTE, INC. , DANA-FARBER CANCER INSTITUTE, INC. , President and Fellows of Harvard College , MASSACHUSETTS INSTITUTE OF TECHNOLOGY
- Applicant Address: US MA Cambridge
- Assignee: THE BROAD INSTITUTE, INC.,DANA FARBER CANCER INSTITUTE, INC.,PRESIDENT AND FELLOWS OF HARVARD COLLEGE,MASSACHUSETTS INSTITUTE OF TECHNOLOGY
- Current Assignee: THE BROAD INSTITUTE, INC.,DANA FARBER CANCER INSTITUTE, INC.,PRESIDENT AND FELLOWS OF HARVARD COLLEGE,MASSACHUSETTS INSTITUTE OF TECHNOLOGY
- Current Assignee Address: US MA Cambridge; US MA Boston; US MA Cambridge; US MA Cambridge
- Agency: Johnson, Marcou, Isaacs & Nix, LLC
- Agent F. Brent Nix, Esq.
- International Application: PCT/US2016/024059 2016.03.24
- International Announcement: WO2016/154459A 2016.09.29
- Date entered country: 2017-09-22
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/50 ; G01N33/574 ; C12M1/26

Abstract:
A method for detecting oncogenic growth and viability, and/or degree of cellular transformation and/or identifying an agent that inhibits cellular transformation is disclosed. The method including: providing a cellular sample, such as a sample of cells obtained from a subject or a cell line; culturing the cellular sample in low attachment conditions; and detecting growth and7or cell viability of the sample, wherein increased growth relative and/or viability relative to a control or control level indicative of basal growth and/or viability indicates cellular transformation. In some embodiments, the method includes introducing a n expression vector into cells of the cellular sample, wherein the expression vector comprises a gene product expression sequence being tested for transformation ability. In some embodiments the cellular sample is contacted with a test agent and growth and/or cell viability of the sample is determined to determine if the agent inhibits transformation.
Public/Granted literature
- US20180051319A1 HIGH-THROUGHPUT DRUG AND GENETIC ASSAYS FOR CELLULAR TRANSFORMATION Public/Granted day:2018-02-22
Information query